Nitto Denko

Bend Labs is a soft silicone sensor platform bringing smarter motion sensing to today's products. It has developed a new soft sensor platform for motion measurement, particularly around human and soft structure motion. The company's patented soft silicone bending, stretch and pressure sensor platforms will be the enabling technology underlying a significant portion of the tens of millions of smart garments, virtual reality gloves, and remote medical devices that are predicted to ship within the next five years. Bend Labs' primary goal is to enable sensor integration by partnering with companies working in the prototyping phase all the way up through large-scale commercial manufacturing and licensing. It was founded in 2013 and is headquartered in Salt Lake City, Utah, United States.

C3Nano specializes in the development of transparent conductive inks and films designed to replace indium tin oxide (ITO) in touch sensors and displays. The company focuses on creating high-performance transparent conductor films and Activegrid silver nanowire solution-based inks, which provide enhanced scratch resistance, durability, and optical clarity. Their products are compatible with various substrates and processing techniques, addressing the growing demand for flexible touch sensor applications. Founded in 2010 and headquartered in Hayward, California, C3Nano has established a significant manufacturing presence in Korea and has raised $37 million in funding to advance its ink formulations and production capabilities.

Algotochip revolutionizes the development of Digital chip (i.e: Systems on a Chip [SOCs]) by radically shortening the time and reducing the cost of the overall design process. This is made possible by their technology's ability to uniquely partition a customer's C-code into optimized modules that generate all the hardware and matched software components required for a complete solution to an application.

Altea Therapeutics Corporation develops and commercializes transdermal drug delivery systems. It offers PassPort patch, a skin patch that uses short bursts of focused thermal energy to create tiny channels in the surface of the skin and these channels permit the flow of proteins, peptides, carbohydrates, and small molecules into the body without the use of needles. The company also provides Transdermal vaccine patch, a delivery system for water-soluble drugs and proteins; disease prevention products; insulin skin patch, a non-injectable daily insulin product; and opioid patches that provide delivery of opioids and incorporates the layers of deterrents. Altea Therapeutics Corporation was formerly known as Altea Development Corporation. The company was founded in 1998 and is based in Atlanta, Georgia. As of May 9, 2012, Altea Therapeutics Corporation operates as a subsidiary of Nitto Denko Corp.

Avecia is a leading private biotechnology company, operating through its OligoMedicines business, focused on the development and manufacture of innovative biotechnology-based medicines. With a long history of technological innovation, they work closely with their customers who are typically biotechnology or pharmaceutical companies, helping them achieve fast progress into, and through, the clinical development programme.